FI20060751A0 - Menetelmä prostatasyövän hoitoon ja mainitusta menetelmästä hyödyntävien potilaiden seulonta - Google Patents
Menetelmä prostatasyövän hoitoon ja mainitusta menetelmästä hyödyntävien potilaiden seulontaInfo
- Publication number
- FI20060751A0 FI20060751A0 FI20060751A FI20060751A FI20060751A0 FI 20060751 A0 FI20060751 A0 FI 20060751A0 FI 20060751 A FI20060751 A FI 20060751A FI 20060751 A FI20060751 A FI 20060751A FI 20060751 A0 FI20060751 A0 FI 20060751A0
- Authority
- FI
- Finland
- Prior art keywords
- screening
- patients
- benefit
- prostate cancer
- treating prostate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20060751A FI20060751A0 (fi) | 2006-08-23 | 2006-08-23 | Menetelmä prostatasyövän hoitoon ja mainitusta menetelmästä hyödyntävien potilaiden seulonta |
| US12/377,357 US20100215638A1 (en) | 2006-08-23 | 2007-08-20 | Method for treatment of prostate cancer and screening of patients benefiting from said method |
| EP07803694A EP2054524A2 (en) | 2006-08-23 | 2007-08-20 | Method for treatment of prostate cancer and screening of patients benefiting from said method |
| EP10151937A EP2272982A1 (en) | 2006-08-23 | 2007-08-20 | Method for treatment of prostate cancer and diagnosing of patients benefiting from the same |
| PCT/FI2007/000204 WO2008023087A2 (en) | 2006-08-23 | 2007-08-20 | Method for treatment of prostate cancer and screening of patients benefiting from said method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20060751A FI20060751A0 (fi) | 2006-08-23 | 2006-08-23 | Menetelmä prostatasyövän hoitoon ja mainitusta menetelmästä hyödyntävien potilaiden seulonta |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI20060751A0 true FI20060751A0 (fi) | 2006-08-23 |
Family
ID=36950652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20060751A FI20060751A0 (fi) | 2006-08-23 | 2006-08-23 | Menetelmä prostatasyövän hoitoon ja mainitusta menetelmästä hyödyntävien potilaiden seulonta |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20100215638A1 (fi) |
| EP (2) | EP2272982A1 (fi) |
| FI (1) | FI20060751A0 (fi) |
| WO (1) | WO2008023087A2 (fi) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008039774A1 (en) | 2006-09-25 | 2008-04-03 | Mayo Foundation For Medical Education And Research | Extracellular and membrane-associated prostate cancer markers |
| WO2008058018A2 (en) | 2006-11-02 | 2008-05-15 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| AU2009253675A1 (en) | 2008-05-28 | 2009-12-03 | Genomedx Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| JP6181638B2 (ja) | 2011-04-28 | 2017-08-16 | ニューヨーク・ユニバーシティ | 前立腺癌における転移のゲノム・シグネチャー |
| GB2493982A (en) * | 2011-08-26 | 2013-02-27 | Univ Leicester | Disease treatments involving histone deacetylases |
| US20130079241A1 (en) | 2011-09-15 | 2013-03-28 | Jianhua Luo | Methods for Diagnosing Prostate Cancer and Predicting Prostate Cancer Relapse |
| CA2858581A1 (en) | 2011-12-13 | 2013-06-20 | Genomedx Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
| US10081842B2 (en) | 2012-08-07 | 2018-09-25 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Prostate cancer gene expression profiles |
| US11035005B2 (en) | 2012-08-16 | 2021-06-15 | Decipher Biosciences, Inc. | Cancer diagnostics using biomarkers |
| US20140107176A1 (en) * | 2012-10-12 | 2014-04-17 | Agency For Science, Technology And Research | Method of modulating a prostate cancer cell |
| CA2935216C (en) | 2013-12-30 | 2021-11-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Fusion genes associated with progressive prostate cancer |
| CA2942485C (en) * | 2014-03-12 | 2022-06-21 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Novel inhibitors for erg oncogene positive cancers |
| US9994912B2 (en) | 2014-07-03 | 2018-06-12 | Abbott Molecular Inc. | Materials and methods for assessing progression of prostate cancer |
| WO2016011428A1 (en) | 2014-07-17 | 2016-01-21 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods of treating cells containing fusion genes |
| US10479997B2 (en) * | 2014-12-01 | 2019-11-19 | Novartis Ag | Compositions and methods for diagnosis and treatment of prostate cancer |
| EP3332037B1 (en) | 2015-08-07 | 2021-02-24 | University of Pittsburgh- Of the Commonwealth System of Higher Education | Methods for predicting prostate cancer relapse |
| US20190204322A1 (en) * | 2015-09-09 | 2019-07-04 | Genomedx Biosciences, Inc. | Molecular subtyping, prognosis and treatment of prostate cancer |
| US11414708B2 (en) | 2016-08-24 | 2022-08-16 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
| EP3571322B9 (en) | 2017-01-20 | 2023-10-04 | VERACYTE SD, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
| EP3593140A4 (en) | 2017-03-09 | 2021-01-06 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
| CA3062716A1 (en) | 2017-05-12 | 2018-11-15 | Decipher Biosciences, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness |
| EP4428157A3 (en) | 2017-08-04 | 2024-12-11 | Veracyte SD, Inc. | Use of immune cell-specific gene expression for prognosis of prostate cancer and prediction of responsiveness to radiation therapy |
| EP4025914A4 (en) * | 2019-09-03 | 2023-09-27 | Envision Sciences Pty Ltd | METHOD FOR CONFIRMING DETECTION AND ASSESSMENT OF PROGRESSION OF PROSTATE CANCER AND ASSOCIATED THERAPIES |
| WO2023168201A1 (en) * | 2022-03-01 | 2023-09-07 | Vanda Pharmaceuticals Inc. | Trichostatin a (tsa) sensitivity in the treatment of tumors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030190635A1 (en) | 2002-02-20 | 2003-10-09 | Mcswiggen James A. | RNA interference mediated treatment of Alzheimer's disease using short interfering RNA |
| EP1386004A4 (en) | 2001-04-05 | 2005-02-16 | Ribozyme Pharm Inc | MODULATION OF GENE EXPRESSION ASSOCIATED WITH INFLAMMATORY PROLIFERATION AND GROWTH OF NEURITIES BY METHODS INVOLVING NUCLEIC ACID |
| US20030175950A1 (en) | 2001-05-29 | 2003-09-18 | Mcswiggen James A. | RNA interference mediated inhibition of HIV gene expression using short interfering RNA |
| US20040019001A1 (en) | 2002-02-20 | 2004-01-29 | Mcswiggen James A. | RNA interference mediated inhibition of protein typrosine phosphatase-1B (PTP-1B) gene expression using short interfering RNA |
| WO2004028471A2 (en) | 2002-09-28 | 2004-04-08 | Massachusetts Institute Of Technology | Influenza therapeutic |
| US20050043266A1 (en) | 2003-07-25 | 2005-02-24 | Sumedha Jayasena | Short interfering RNA as an antiviral agent for hepatitis C |
| CA2565450C (en) * | 2004-05-07 | 2018-03-06 | Gyorgy Petrovics | Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer |
-
2006
- 2006-08-23 FI FI20060751A patent/FI20060751A0/fi not_active Application Discontinuation
-
2007
- 2007-08-20 EP EP10151937A patent/EP2272982A1/en not_active Withdrawn
- 2007-08-20 EP EP07803694A patent/EP2054524A2/en not_active Withdrawn
- 2007-08-20 WO PCT/FI2007/000204 patent/WO2008023087A2/en not_active Ceased
- 2007-08-20 US US12/377,357 patent/US20100215638A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20100215638A1 (en) | 2010-08-26 |
| EP2054524A2 (en) | 2009-05-06 |
| EP2272982A1 (en) | 2011-01-12 |
| WO2008023087A3 (en) | 2008-07-03 |
| WO2008023087A2 (en) | 2008-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI20060751A0 (fi) | Menetelmä prostatasyövän hoitoon ja mainitusta menetelmästä hyödyntävien potilaiden seulonta | |
| EP1991230A4 (en) | METHOD FOR THE TREATMENT OF CANCER | |
| IL197217B (en) | Novel anti-cd38 antibodies for the treatment of cancer | |
| HRP20130344T1 (xx) | Ploäśica buprenorfina za nadomjesno lijeäśenje ovisnosti o drogama | |
| FI20075533A0 (fi) | Hiomatuote ja menetelmä tämän valmistamiseksi | |
| IL193099A0 (en) | Method of treating chronic kidney disease | |
| BRPI0908129A2 (pt) | Método de tratamento de câncer de próstata em estágio metastático | |
| PT2529626T (pt) | Composições e métodos para tratamento ou prevenção do cancro do cólon | |
| HUE054495T2 (hu) | Rák kezelésére szolgáló készítmény | |
| IL185690A0 (en) | Method for treating prostate diseases based on local delivery of active substances | |
| DK2056842T3 (da) | Modificeret galactosylceramid til behandling af cancerøse sygdomme | |
| EP2163896A4 (en) | METHOD FOR DETECTION OR TREATMENT OF GRAFT DISEASE AGAINST HOST | |
| IL192600A0 (en) | Method of treating or preventing tissue damage caused by increased blood flow | |
| SE0400346L (sv) | Steroider för cancerbehandling | |
| FI20065438A0 (fi) | Häiriönpoistoyksikkö ja häiriönpoistomenetelmä | |
| FI20065691A0 (fi) | Menetelmä ja laite taimien istuttamiseksi | |
| FI20060995A0 (fi) | Luonnollisen kielen käsittely | |
| EP2068911A4 (en) | METHOD FOR THE TREATMENT OF CANCER | |
| BR112012003653A2 (pt) | "método de tratar o câncer." | |
| MA28901B1 (fr) | Methode de traitement de cancers | |
| EP2063271A4 (en) | TUMOR MARKERS FOR KIDNEY CANCER AND METHOD FOR DETERMINING THE PRESENCE OF KIDNEY CANCER | |
| EP2214485A4 (en) | METHOD FOR THE TREATMENT OF CANCER | |
| FI20060849L (fi) | Menetelmä ja laitteisto öljynporausjätteen käsittelemiseksi | |
| MA28691B1 (fr) | Procede de traitement du cancer | |
| EP1791969A4 (en) | METHOD FOR THE TREATMENT OF CANCER |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |